IMMUNE DEFICIENCY FOUNDATION
EIN: 52-1214782Hanover, MDZIP: 21706
H9CZ - Medical Research501(c)(3)
Misión
THE IMMUNE DEFICIENCY FOUNDATION IMPROVES THE DIAGNOSIS, TREATMENT, AND QUALITY OF LIFE FOR EVERY PERSON AFFECTED BY PRIMARY IMMUNODEFICIENCY. WE FOSTER A COMMUNITY THAT IS CONNECTED, ENGAGED, AND EMPOWERED THROUGH ADVOCACY, EDUCATION, AND RESEARCH.
Finanzas
| Año | Ingresos | Gastos | Activos |
|---|---|---|---|
| 2024 | $10.1M | $0 | $18.8M |
| 2023 | $9M | $0 | $17.4M |
Compensación
2024
2023
Organizaciones similares
NATIONAL FOUNDATION FOR CANCER RESEARCH
$9.2M ingresosRockville, MD
Sector similar (H)Ingresos muy similares ($9.2M vs $10.1M)Mismo estado (Maryland)Niveles de compensación comparables
FOUNDATION FIGHTING BLINDNESS
$8.8M ingresosColumbia, MD
Sector similar (H)Ingresos similares ($8.8M vs $10.1M)Mismo estado (Maryland)Compensación mediana similar ($165k vs $169k)
ANATOMIC GIFT FOUNDATION INC
$7.7M ingresosHanover, MD
Sector similar (H)Ingresos similares ($7.7M vs $10.1M)Mismo estado (Maryland)Compensación mediana similar ($172k vs $169k)
Baltimore Research and Education
$8.1M ingresosBaltimore, MD
Sector similar (H)Ingresos similares ($8.1M vs $10.1M)Mismo estado (Maryland)
BLADDER CANCER ADVOCACY NETWORK
$6.4M ingresosBethesda, MD
Sector similar (H)Ingresos comparables ($6.4M vs $10.1M)Mismo estado (Maryland)Compensación mediana similar ($172k vs $169k)
Heart Failure Society of America Inc
$7.3M ingresosRockville, MD
Sector similar (H)Ingresos comparables ($7.3M vs $10.1M)Mismo estado (Maryland)Compensación mediana similar ($157k vs $169k)
AOAC INTERNATIONAL
$6.6M ingresosRockville, MD
Sector similar (H)Ingresos comparables ($6.6M vs $10.1M)Mismo estado (Maryland)
CVPATH INSTITUTE INC
$13.1M ingresosGaithersburg, MD
Sector similar (H)Ingresos comparables ($13.1M vs $10.1M)Mismo estado (Maryland)
CENTER FOR DISEASE DYNAMICS ECONOMICS &
$5.4M ingresosSilver Spring, MD
Sector similar (H)Ingresos comparables ($5.4M vs $10.1M)Mismo estado (Maryland)
Datos de declaraciones del Formulario 990 del IRS (2023-2024).